The AI will see you now: A deep dive into AI's impact on clinical decision support

We leverage the results of a proprietary survey of c.80 US healthcare professionals to provide a deep-dive into clinical decision support solutions (CDS) and how they are impacted by AI. Two conclusions: 1) Reiterate Buy on Wolters Kluwer: In the context of heightened AI concerns and deeply discounted valuation, we come away incrementally reassured on sustainability of group revenue growth, leaving risk/reward attractive; and 2) Doximity could gain share in the enterprise hospital market, but we have concerns on the broader impact from rising competition. CDS has emerged as a key focus area - we estimate just c.1-3% of healthcare IT budgets today but viewed as a very important resource by c.85% of our survey respondents. We find >80% of clinicians expect usage of CDS to rise. WKL's UpToDate (12% of sales) is the most used CDS according to our survey;